Measuring lung function in murine models of pulmonary disease

Peter D. Sly, Debra J. Turner, Z. Hantos

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Mice are commonly used to model human lung diseases. However, their small size poses substantial problems for accurately measuring lung function. Noninvasive techniques have been widely used but have severe limitations and should be restricted to screening for the presence of disease. Accurate measures of lung function and assessment of the site of disease pathology and drug action are possible using invasive techniques. Investigators must understand the strengths and weaknesses of each technique before deciding which to use.

Original languageEnglish
Pages (from-to)337-343
Number of pages7
JournalDrug Discovery Today: Disease Models
Volume1
Issue number3
DOIs
Publication statusPublished - Dec 17 2004

Fingerprint

Lung Diseases
Lung
Research Personnel
Pathology
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Drug Discovery
  • Molecular Medicine

Cite this

Measuring lung function in murine models of pulmonary disease. / Sly, Peter D.; Turner, Debra J.; Hantos, Z.

In: Drug Discovery Today: Disease Models, Vol. 1, No. 3, 17.12.2004, p. 337-343.

Research output: Contribution to journalArticle

Sly, Peter D. ; Turner, Debra J. ; Hantos, Z. / Measuring lung function in murine models of pulmonary disease. In: Drug Discovery Today: Disease Models. 2004 ; Vol. 1, No. 3. pp. 337-343.
@article{1cb91870c61140698efa6a93a2d5d12c,
title = "Measuring lung function in murine models of pulmonary disease",
abstract = "Mice are commonly used to model human lung diseases. However, their small size poses substantial problems for accurately measuring lung function. Noninvasive techniques have been widely used but have severe limitations and should be restricted to screening for the presence of disease. Accurate measures of lung function and assessment of the site of disease pathology and drug action are possible using invasive techniques. Investigators must understand the strengths and weaknesses of each technique before deciding which to use.",
author = "Sly, {Peter D.} and Turner, {Debra J.} and Z. Hantos",
year = "2004",
month = "12",
day = "17",
doi = "10.1016/j.ddmod.2004.11.016",
language = "English",
volume = "1",
pages = "337--343",
journal = "Drug Discovery Today: Disease Models",
issn = "1740-6757",
publisher = "Elsevier Limited",
number = "3",

}

TY - JOUR

T1 - Measuring lung function in murine models of pulmonary disease

AU - Sly, Peter D.

AU - Turner, Debra J.

AU - Hantos, Z.

PY - 2004/12/17

Y1 - 2004/12/17

N2 - Mice are commonly used to model human lung diseases. However, their small size poses substantial problems for accurately measuring lung function. Noninvasive techniques have been widely used but have severe limitations and should be restricted to screening for the presence of disease. Accurate measures of lung function and assessment of the site of disease pathology and drug action are possible using invasive techniques. Investigators must understand the strengths and weaknesses of each technique before deciding which to use.

AB - Mice are commonly used to model human lung diseases. However, their small size poses substantial problems for accurately measuring lung function. Noninvasive techniques have been widely used but have severe limitations and should be restricted to screening for the presence of disease. Accurate measures of lung function and assessment of the site of disease pathology and drug action are possible using invasive techniques. Investigators must understand the strengths and weaknesses of each technique before deciding which to use.

UR - http://www.scopus.com/inward/record.url?scp=23644455991&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23644455991&partnerID=8YFLogxK

U2 - 10.1016/j.ddmod.2004.11.016

DO - 10.1016/j.ddmod.2004.11.016

M3 - Article

AN - SCOPUS:23644455991

VL - 1

SP - 337

EP - 343

JO - Drug Discovery Today: Disease Models

JF - Drug Discovery Today: Disease Models

SN - 1740-6757

IS - 3

ER -